title: Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.
abstract: The Cl- secretory pathway that is defective in cystic fibrosis (CF) can be bypassed by an alternative pathway for Cl- transport that is activated by extracellular nucleotides. Accordingly, the P2 receptor that mediates this effect is a therapeutic target for improving Cl- secretion in CF patients. In this paper, we report the sequence and functional expression of a cDNA cloned from human airway epithelial (CF/T43) cells that encodes a protein with properties of a P2U nucleotide receptor. With a retrovirus system, the human airway clone was stably expressed in 1321N1 astrocytoma cells, a human cell line unresponsive to extracellular nucleotides. Studies of inositol phosphate accumulation and intracellular Ca2+ mobilization induced by extracellular nucleotides in 1321N1 cells expressing the receptor identified this clone as the target receptor in human airway epithelia. In addition, we independently isolated an identical cDNA from human colonic epithelial (HT-29) cells, indicating that this is the same P2U receptor that has been functionally identified in other human tissues. Expression of the human P2U receptor (HP2U) in 1321N1 cells revealed evidence for autocrine ATP release and stimulation of transduced receptors. Thus, HP2U expression in the 1321N1 cell line will be useful for studying autocrine regulatory mechanisms and in screening of potential therapeutic drugs.
authors.affiliation: Division of Pulmonary Diseases, University of North Carolina, Chapel Hill 27599-7020.
authors.forename: C E
authors.initials: CE
authors.lastname: Parr
authors.forename: D M
authors.initials: DM
authors.lastname: Sullivan
authors.forename: A M
authors.initials: AM
authors.lastname: Paradiso
authors.forename: E R
authors.initials: ER
authors.lastname: Lazarowski
authors.forename: L H
authors.initials: LH
authors.lastname: Burch
authors.forename: J C
authors.initials: JC
authors.lastname: Olsen
authors.forename: L
authors.initials: L
authors.lastname: Erb
authors.forename: G A
authors.initials: GA
authors.lastname: Weisman
authors.forename: R C
authors.initials: RC
authors.lastname: Boucher
authors.forename: J T
authors.initials: JT
authors.lastname: Turner
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology; D000595:Amino Acid Sequence; D001483:Base Sequence; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology; D018118:Chloride Channels / Q000235:genetics*; D003001:Cloning, Molecular; D017931:DNA Primers / Q000737:chemistry; D018076:DNA, Complementary / Q000235:genetics; D015870:Gene Expression; D005796:Genes; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000235:genetics; D011956:Receptors, Cell Surface / Q000235:genetics*; D018048:Receptors, Purinergic P2 / Q000235:genetics* / Q000378:metabolism; D058473:Receptors, Purinergic P2Y2; D015398:Signal Transduction; D014018:Tissue Distribution; D014544:Uridine Triphosphate / Q000494:pharmacology
chemical_list: D018118:Chloride Channels; D017931:DNA Primers; D018076:DNA, Complementary; D007295:Inositol Phosphates; C546385:P2RY2 protein, human; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D018048:Receptors, Purinergic P2; D058473:Receptors, Purinergic P2Y2; D000255:Adenosine Triphosphate; D002217:Carbachol; D002118:Calcium; D014544:Uridine Triphosphate